COSMOS Pharmaceutical Corporation

¥6,340As of Sun 8 Nov 2026, 12:00 UTC
TSE:3349Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 1.68%
Div yield 1.32%
ROE 11.66%
Medical (Pharmaceuticals)
Beta (5Y) 0.19
PE TTM 15.64
TSR TTM (6.94%)
Mkt cap ¥502.5B
ROIC 9.87%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7,181
13.26%
(54.29%)
Hold 1|12|6|5|7
2Q26
3Q26
4Q26
1Q27
Earnings per share¥
89.61
94.19
94.50
103.94
16.14%
9.32%
7.78%
19.90%
Revenue¥B
28.64
30.15
31.42
32.74
11.05%
11.54%
18.97%
19.45%
Peers (US$3.190B)
Cap (US$)
PE
3.139B
16.43x
2.864B
23.92x
2.777B
13.90x
Capital
TTM
5Y
10Y
Leveragex
3.305
(0.297)
(0.253)
EBIT/Intx
0.496
0.126
0.139
Own earn%
(21.25)
173.55
166.56
Sh yield%
40.36
25.42
26.57
Owners
Insiders/Inst%
1.13
20.93
Short interest%
5.29
SBC / revenue%
3.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
11–18
$1 testx
1.3
Incr. ROIC%
4